Drawing for Serial No. 79307445

USPTO serial 79307445

Serial No. 79307445

Reviewed by CopyMark Law Group

Reg. 6733756Status 700Registered
Filing date
Status date
Registration date
May 24, 2022
Examiner
DUBOIS, SUSAN L
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with Serial No. 79307445?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Corey K. Cho

Corey K. Cho Saliwanchik Lloyd & Eisenschenk, P.A.3107 SW Williston RdGainesville, FL 32608UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Reagents for detecting or analyzing genetic material; diagnostic reagents for in vitro use in biochemistry, clinical chemistry or microbiology; reagents for analyzing nucleic acid for industrial, scientific or laboratory purposes; reagents for use in genetic research; polymerase for nucleic acid amplifications for scientific or laboratory purposes; nucleic acid for scientific or laboratory purposes; diagnostic preparations for scientific or laboratory use; reagents for scientific or laboratory use, namely, nucleic acid and chemicals used for their synthesis; reagents for scientific, research or laboratory use; in vitro diagnostic reagents for scientific, research or laboratory use; chemicals for industrial purposes; chemical preparations for scientific purposes; chemical reagents, other than for medical or veterinary purposes; chemical preparations for analyses in laboratories, other than for medical purposes; chemical preparations in the nature of ion exchangers; electrophoresis gels, other than for medical or veterinary purposes; diagnostic preparations, other than for medical or veterinary purposes; chemical reagents, other than for medical or veterinary purposes; enzymes for chemical purposes for research or scientific purposes; industrial chemicals; microorganisms, other than for medical purposes; cultures of microorganisms, other than for medical and veterinary use; preparations of microorganisms, other than for medical and veterinary use; bacterial preparations other than for medical or veterinary use; biological tissue cultures other than for medical or veterinary purposes; biological preparations, other than for medical or veterinary purposes; stem cells, other than for medical or veterinary purposes; photometric paper for scientific use; chemical test paper; reagent paper, other than for medical or veterinary purposesACTIVE—
009DNA chips; biochips for research or scientific purposes; incubators for bacteria culture; food analysis apparatus; chemistry apparatus and instruments, namely, test tubes, pipette tips or swabs; optical apparatus and instruments except for glasses and photographic apparatus, namely, optical sensors, optical inspection apparatus, optical detectors and optical lenses; apparatus for testing protein or nucleic acid not for medical purposes; diagnostic apparatus, for the detection of pathogens for laboratory or research use, not for medical purposes; immunofluorescence measuring apparatus not for medical purposes; absorption measuring apparatus not for medical purposes; gene amplifiers; real-time gene amplification equipment; apparatus for analyzing biomolecules for laboratory use; laboratory apparatus and instruments for preparing nucleic acid samples; laboratory apparatus for extracting and purifying nucleic acid; nucleic acid amplification apparatus for laboratory use; real-time nucleic acid amplification apparatus for laboratory use; diagnostic chips for medical purposesACTIVE—
010Apparatus for use in medical analysis, namely, protein analysis apparatus for medical purposes, blood analysis apparatus for medical purposes, and immunofluorescence analysis apparatus for medical purposes; diagnostic apparatus for medical purposes, used for the diagnosis of infection of microorganisms; testing apparatus for medical purposes, namely, bacteria and virus testing apparatus for medical purposes, blood cell testing apparatus for medical purposes, immune testing apparatus for medical purposes, and gene testing apparatus for medical purposes; apparatus for clinical diagnosis, namely, clinical diagnosis apparatus for genetic diseases, and clinical diagnosis apparatus for infectious diseases; medical apparatus and instruments for extracting and purifying protein; apparatus for taking specimen for medical purposes; medical apparatus and instruments for extracting and purifying nucleic acid; nucleic acid amplification apparatus for medical use; real-time gene amplification equipment for medical use; medical analysis apparatus for use in gene analysis and genetic disease diagnosis; body fluid and tissues sample analysis apparatus for medical purposes; nucleic acid analysis apparatus for medical purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 10, 2022FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 15, 2022FICSFINAL DISPOSITION NOTICE SENT TO IB—
Sep 15, 2022FIMPFINAL DISPOSITION PROCESSED—
Aug 24, 2022FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 24, 2022NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
May 24, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 8, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 8, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 7, 2022GPNXNOTIFICATION PROCESSED BY IB—
Feb 16, 2022OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Feb 16, 2022OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Feb 16, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 1, 2022ALIEASSIGNED TO LIE—
Jan 31, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 18, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 17, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 17, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 20, 2021RFNTREFUSAL PROCESSED BY IB—
Aug 31, 2021RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Aug 30, 2021RFRRREFUSAL PROCESSED BY MPU—
Aug 14, 2021RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Aug 13, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 11, 2021DOCKASSIGNED TO EXAMINER—
Jun 12, 2021NREPNEW REPRESENTATIVE AT IB RECEIVED—
Mar 30, 2021MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 26, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 25, 2021REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance